Faes Farma SA (MC:FAE) — Market Cap & Net Worth
Market Cap & Net Worth: Faes Farma SA (FAE)
Faes Farma SA (MC:FAE) has a market capitalization of $1.40 Billion (€1.19 Billion) as of September 16, 2026. Listed on the MC stock exchange, this Spain-based company holds position #7507 globally and #64 in its home market, demonstrating a 0.56% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Faes Farma SA's stock price €4.52 by its total outstanding shares 311454805 (311.45 Million). Also see Faes Farma SA assets under control for a full breakdown of the balance sheet.
Faes Farma SA Market Cap History: 2015 to 2026
Faes Farma SA's market capitalization history from 2015 to 2026. Data shows growth from $746.05 Million to $1.64 Billion (8.93% CAGR). Also see FAE cash flow conversion for how efficiently the company converts equity into cash flow.
Faes Farma SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Faes Farma SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Faes Farma SA (FAE) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
3.08x
Faes Farma SA's market cap is 3.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
23.60x
Faes Farma SA's market cap is 23.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $932.63 Million | $228.63 Million | $36.59 Million | 4.08x | 25.49x |
| 2017 | $842.55 Million | $274.58 Million | $42.22 Million | 3.07x | 19.96x |
| 2018 | $880.45 Million | $324.31 Million | $51.59 Million | 2.71x | 17.07x |
| 2019 | $1.52 Billion | $357.40 Million | $63.96 Million | 4.26x | 23.79x |
| 2020 | $1.11 Billion | $380.24 Million | $72.55 Million | 2.91x | 15.25x |
| 2021 | $1.16 Billion | $398.56 Million | $82.39 Million | 2.91x | 14.06x |
| 2022 | $1.18 Billion | $438.75 Million | $89.50 Million | 2.68x | 13.15x |
| 2023 | $1.11 Billion | $451.17 Million | $91.90 Million | 2.46x | 12.07x |
| 2024 | $1.27 Billion | $493.65 Million | $111.36 Million | 2.57x | 11.38x |
| 2025 | $1.88 Billion | $610.46 Million | $79.63 Million | 3.08x | 23.60x |
Competitor Companies of FAE by Market Capitalization
Companies near Faes Farma SA in the global market cap rankings as of September 16, 2026. Review FAE goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Faes Farma SA by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Faes Farma SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Faes Farma SA's market cap moved from $746.05 Million to $ 1.64 Billion, with a yearly change of 8.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.64 Billion | -12.50% |
| 2025 | €1.88 Billion | +48.28% |
| 2024 | €1.27 Billion | +14.23% |
| 2023 | €1.11 Billion | -5.76% |
| 2022 | €1.18 Billion | +1.65% |
| 2021 | €1.16 Billion | +4.65% |
| 2020 | €1.11 Billion | -27.28% |
| 2019 | €1.52 Billion | +72.82% |
| 2018 | €880.45 Million | +4.50% |
| 2017 | €842.55 Million | -9.66% |
| 2016 | €932.63 Million | +25.01% |
| 2015 | €746.05 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Faes Farma SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.40 Billion USD |
| MoneyControl | $1.40 Billion USD |
| MarketWatch | $1.40 Billion USD |
| marketcap.company | $1.40 Billion USD |
| Reuters | $1.40 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Faes Farma SA
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants servic… Read more